Tag: Ipsen

Ipsen Warns about Brexit Influence on Pharma

France’s Ipsen has become the latest pharma company to warn about the impact of Brexit on the pharma industry and patients’ access to medicines. As Theresa May attempts to drum up support for her B...

Ipsen becomes a member of Biotechnology Innovation Organization

Ipsen announced it has joined the Biotechnology Innovation Organization (BIO), the largest association of biotechnology companies, academic institutions and biotech centers.

Ipsen partnered with MD Anderson Cancer Center to develop new cancer drug

cancer treatment
Ipsen, a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate.

Arix Bioscience and Ipsen start cooperation on innovative therapies

Arix Bioscience, a global healthcare and life science company, and Ipsen, a global specialty-driven biopharmaceutical company announced a strategic agreement to develop and commercialise innovative therapies.